Italfarmaco Announces U.S. FDA Grants Fast Track Designation to Givinostat in Treatment of Polycythemia Vera

34 minutes ago
GlobeNewswire

MILAN, Italy, May 6, 2025 – Italfarmaco S.p.A. announced today that the U.S. Food and Drug Administration (FDA) has granted…

Akropolis Group has mandated Citigroup Global Markets Europe AG, ING Bank N.V. and Skandinaviska Enskilda Banken AB (publ) to coordinate bond issuance process and commence meetings with investors

2 hours ago

This announcement relates to the disclosure of information in relation to the Notes that qualifies or may have qualified as…

Announcement concerning large shareholders under the Danish Capital Markets Act

2 hours ago

Nasdaq CopenhagenEuronext DublinLondon Stock Exchange        Other stakeholders Date    6 May 2025 Announcement concerning large shareholders under the Danish Capital Markets…

Romanian Producer Inflation Slows in March

3 hours ago

In March 2025, Romania experienced a decline in its annual producer inflation rate, which dropped to 3.32% from 4.03% in…

French Industrial Production Growth Slows to a Crawl in March 2025

3 hours ago

In a stark deceleration from previous months, French industrial production growth has substantially eased, with the current indicator halting at…

Australian Shares Fall for Second Session

3 hours ago

On Tuesday, the S&P/ASX 200 Index fell by 0.08%, closing at 8,151, marking its second consecutive day of decline due…

Silver Climbs for Second Session

3 hours ago

Silver prices advanced by nearly 2%, reaching approximately $33 per ounce on Tuesday, building on gains from the prior session.…

Romania’s Producer Price Index Shows Deceleration in March

3 hours ago

Romania's Producer Price Index (PPI) has demonstrated a slight deceleration in March 2025, marking a continued trend of price moderation…

Essential Pharma strengthens management team with appointment of Duncan Ferguson as Vice President, Commercial

3 hours ago

Egham, UK – 6th May 2025 – Essential Pharma (“Essential” or “the Company”), a global pharmaceutical company developing and delivering…

Priothera Appoints Dr. Jens Hasskarl as Chief Medical Officer to Drive Late-Stage Clinical Development of Mocravimod, a S1P Receptor Modulator for Acute Myeloid Leukemia (AML)

3 hours ago

Dr. Hasskarl to lead global Phase 3 MO-TRANS study evaluating mocravimod as an adjunctive treatment to allo-HCT in AML Saint-Louis,…

This website uses cookies.